NASDAQ: MOBI · Industrial Applications and Services · 4 alerts · CIK 1489993
Share price
$13.15Close, Nov 16
Market cap
$438M
Shares outstanding
33.33MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Surgical & Medical Instruments & ApparatusSIC 3841
Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Mobia Medical, Inc. filings on SEC EDGAR ↗
Mobia Medical reported significant revenue growth for the nine months ended September 30, 2026, reaching $41.2 million compared to $21.3 million in the prior year. However, the company remains in a net loss position with an accumulated deficit of $213.9 million, primarily driven by high selling, general, and administrative expenses as it scales operations following its initial public offering.
Mobia Medical reported Q3 2026 revenue of $15.6 million, a 73% year-over-year increase driven by broader adoption of its Vivistim System. The company also raised its full-year 2026 revenue guidance to a range of $57.0 million to $57.5 million, reflecting strong commercial execution and territory expansion.
Term
Q3 2026
“This quarter, we delivered our strongest results yet. Revenue growth of 73% reflects the strength of our commercial execution and the predictable nature of our patient funnel.”
Richard Foust, President and Chief Executive Officer
“Additionally, we were pleased to announce the inclusion of paired VNS in the updated AHA Stroke guidelines for 2026, serving as validation of our evidence-based approach to stroke recovery and further recognition of how Vivistim® Paired VNS™ Therapy can redefine what is possible for stroke survivors.”
Richard Foust, President and Chief Executive Officer
Mobia Medical, Inc. appointed Myriam J. Curet, M.D., to its nominating and corporate governance committee, effective October 15, 2026. This filing is an amendment to a previous 8-K to finalize her committee assignment following her earlier election to the Board of Directors.
Mobia Medical, Inc. announced that the Board of Directors appointed Dr. Reza Zadno to its audit committee, effective October 15, 2026. Dr. Zadno, who was previously elected to the Board, will also continue to serve on the company's compensation committee.